SS

Shruti Singh

Active Director Director DIN 09141043
DIN 09141043 First appointment Apr 2021 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2021
Shareholding value •••• Premium profile

About Shruti Singh

Data last updated:

Shruti Singh is a Director at Renes Medical Center India Private Limited (since 2021). The company operates in Healthcare. Renes Medical Center India Private Limited reported revenue of ₹8.1 Lakh (FY 2023).

DIN 09141043
Primary Designation Director
Industry Healthcare
First Appointment 09 Apr 2021
Oldest Company Age 5 yrs
Largest company Renes Medical Center India Private Limited · ₹8.1 Lakh (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 Apr 20212021₹8.1 Lakh (FY 2023)Active

Board colleagues of Shruti Singh

Directorship timeline

Open interactive timeline →
Renes Medical Center India Private Limited
Premium access

Shareholding and investment profile for Shruti Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shruti Singh

Shruti Singh currently holds 1 directorship: Renes Medical Center India Private Limited (Director, since 09 Apr 2021, revenue ₹8.1 Lakh (FY 2023)).

Shruti Singh was first appointed on 09 Apr 2021 as Director at Renes Medical Center India Private Limited.

The current boards of Shruti Singh's companies include Satwik Saurav (Renes Medical Center India Private Limited), Shobha Pandey (Renes Medical Center India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available